Dialectal influence on chronic pulmonary disease assessment test: The reliability and validity study

International Journal of COPD

Volumn 10, Issue , 2015, Pages 541-548

  Pothirat, Chaicharn ^a   Chaiwong, Warawut ^a   Phetsuk, Nittaya ^a   Liwsrisakun, Chalerm ^a   Bumroongkit, Chaiwat ^a   Deesomchok, Athavudh ^a   Theerakittikul, Theerakorn ^a   Limsukon, Atikun ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Chronic obstructive pulmonary disease; COPD assessment test; Quality of life; Reliability; Validation

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LONG ACTING DRUG;

6 MINUTE WALK DISTANCE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COPD ASSESSMENT TEST; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERNAL CONSISTENCY; LANGUAGE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL SCALE; QUALITY OF LIFE; SCORING SYSTEM; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TEST RETEST RELIABILITY; THAILAND; VALIDITY; COMPARATIVE STUDY; COMPREHENSION; CROSS-SECTIONAL STUDY; DISABILITY; HEALTH STATUS; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; REPRODUCIBILITY; VALIDATION STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMPREHENSION; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HUMANS; LANGUAGE; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SURVEYS AND QUESTIONNAIRES; THAILAND;

EID: 84929411549     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S79041     Document Type: Article

References (18)

1. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946.
2. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269–1276.
3. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349: 1436–1442.
4. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349:1498–1504.
5. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. Aself-complete measure of health status for chronic airflow limitation: the St George’s respiratory questionnaire. Am Rev Respir Dis. 1992;145:1321–1327.
6. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. Ameasure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778.
7. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34:648–654.
8. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD; 2014. Available from: http://www.goldcopd.org. Accessed August 1, 2014.
9. Jones PW, Quirk FH, Baveystock CM. The St George’s respiratory questionnaire. Respir Med. 1991;85(suppl B):25–31.
10. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586.
11. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127(6):725−734.
12. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117.
13. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334.
14. Stallberg B, Nokela M, Ehrs PO, Hjemdal P, Jonsson EW. Validation of the clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes. 2009;7:26.
15. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011; 38:29–35.
16. Jones P, Miravitlles M, van der Molen T, Kulich K. Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis. 2012;7:697–709.
17. Hajiro T, Nishimura K, Tsukino M, Ikada A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(3 pt 1):785–790.
18. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994.